Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation | MicrobiomeTrials← Back to trialsNCT07575269
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07-20Est. Completion: 2028-07-20
Enrollment target: 571 participants Locations- Arrhythmia Research Group, Jonesboro, Arkansas, United States
- Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
- Mount Sinai Medical Center-Hospital, New York, New York, United States
- Texas Cardiac Arrhythmia Research, Austin, Texas, United States
- Christus Trinity Mother Frances Health System-Hospital, Tyler, Texas, United States
- Mater Private Hospital-Hospital, Dublin, Dublin, Ireland
Other microbiome trials you might be interested in
Atrial FibrillationPersistent Atrial FibrillationParoxysmal AF
The objective of this feasibility study is to evaluate the safety and effectiveness of the FARAFLEX mapping and pulsed f…
Brussels, BelgiumEst. completion Feb 15, 2027
Paroxysmal Atrial Fibrillation
To collect clinical data on safety, effectiveness and procedural success of Boston Scientific's Cardiac Cryoablation Sys…
Gilbert, United StatesCompleted May 20, 2026